SITAGLIPTIN - METFORMIN- sitagliptin - metformin tablet 
Truemed Group LLC

----------

SITAGLIPTIN - METFORMIN

History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema. [See Warnings and Precautions (5.4); Adverse Reactions (6.2).]

SITAGLIPTIN/METFORMIN 50/850MGSITAGLIPTIN/METFORMIN 50/850MG

SITAGLIPTIN - METFORMIN 
sitagliptin - metformin tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:82922-100
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METFORMIN (UNII: 9100L32L2N) (METFORMIN - UNII:9100L32L2N) METFORMIN850 mg
SITAGLIPTIN (UNII: QFP0P1DV7Z) (SITAGLIPTIN - UNII:QFP0P1DV7Z) SITAGLIPTIN50 mg
Product Characteristics
ColorredScoreno score
ShapeBULLETSize10mm
FlavorImprint Code 50850
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82922-100-0128 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product04/14/2023
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Export only04/14/2023
Labeler - Truemed Group LLC (004154534)
Establishment
NameAddressID/FEIBusiness Operations
Truemed Group LLC004154534pack(82922-100) , label(82922-100)

Revised: 4/2023
Document Id: f9519812-a5b1-1a19-e053-6294a90a471d
Set id: f9519812-a5b0-1a19-e053-6294a90a471d
Version: 1
Effective Time: 20230414
 
Truemed Group LLC